The field of psychiatry is hampered by a lack of robust, reliable and valid biomarkers that can
aid in objectively diagnosing patients and providing individualized treatment …

People with schizophrenia die 15‐20 years prematurely. Understanding mortality risk and
aggravating/attenuating factors is essential to reduce this gap. We conducted a systematic …

Schizophrenia is a chronic and debilitating condition with a global prevalence of
approximately 1% varying by location and diagnostic criterion. 1, 2 The average age of …

Background The limited studies that focused on suicidality in individuals at Ultra-High Risk
(UHR) of psychosis were predominantly cross-sectional, emerging from Western countries …

Little is known about the risk factors for deliberate self-harm (DSH) and suicide among
adolescents and young adults with first episode psychosis (FEP) and the longitudinal course …

Suicide is the leading cause of unnatural death among people with a diagnosis of
schizophrenia. Alcohol use is a prevalent comorbid feature of schizophrenia and a …

This continuing education supplement is jointly provided by Medical Education Resources
and CMEology. The supplement is supported by an independent educational grant from …

Abstract The Columbia Suicide Severity Rating Scale (C–SSRS) is considered the gold
standard for collecting information on suicidal ideation and behavior by the Food and Drug …

Context Mental health comorbidities among individuals with serious illness are prevalent
and negatively impact outcomes. Mental healthcare is a core domain of palliative care, but …

Aims Suicide ideation, self-harm, and suicide are common in patients with schizophrenia,
but the reported prevalence vary largely across studies. Improved prevalence estimates and …